Dr. Reddy's Laboratories Limited

Healthcare

NYSE:RDY · New York Stock Exchange

Market Cap $11.07B Beta 0.26 P/E (TTM) 24.8

$13.30 -0.45%

-$0.06 today

52W Low $12.19High $15.97

Vol 1.01M · Avg 2.44M

EPS (TTM)$51.40

Div Yield0.63%

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-15.39%

Period High

$15.72

Period Low

$12.46

Latest

$13.30

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Revolution Medicines, Inc.

NASDAQ:RVMD

$32.71B

Viatris Inc.

NASDAQ:VTRS

$19.19B

Neurocrine Biosciences, Inc.

NASDAQ:NBIX

$16.06B

Solventum Corporation

NYSE:SOLV

$13.66B

Exelixis, Inc.

NASDAQ:EXEL

$13.35B

Elanco Animal Health Incorporated

NYSE:ELAN

$12.07B

Revvity, Inc.

NYSE:RVTY

$11.12B

BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

$10.81B

Encompass Health Corporation

NYSE:EHC

$10.07B

The Ensign Group, Inc.

NASDAQ:ENSG

$8.73B

What is the latest RDY filing?

The latest filing shown is 6-K dated Jun 10, 2026.

How many recent filings does RDY have?

Intrinsic Alpha currently shows 20 recent filings for RDY.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.